• Cirsium japonicum (CSJ) alleviates ovalbumin (OVA)-induced allergic rhinitis (AR) • CSJ reduces serum anti-OVA IgE, histamine, and IL-13 levels and nasal inflammation • O-Linked glycosylation of mucins, MUC5AC, and NRF2 are key targets of CSJ in AR • Cryptochlorogenic acid and cirsimarin in CSJ bind directly to NRF2–KEAP1 and MUC5AC • CSJ shows potential for AR therapeutic agent via the NRF2 pathway and MUC5AC expression regulation
No takes yet. Share an insight, caveat, or question.
Pyun et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: